Loren Bausell and Katherine Wolf
USAID DELIVER PROJECT, Task Order 7; June, 2015
Throughout Africa, 30 million pregnant women are exposed to malaria each year. Malaria in pregnancy carries increased risk of low birth weight, severe maternal anaemia, maternal mortality, miscarriage, premature delivery, and stillbirth. To address malaria during pregnancy, the Roll Back Malaria Consortium advocates a three-pronged approach, one aspect of which is the delivery of intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP). The report looks at Malawi to analyze the relationship between SP stockout rates and coverage of SP for intermittent preventative treatment of malaria in pregnant women. This analysis was performed to explore the relationship between stock availability and intervention coverage.